Rising Malaria Cases Drive Next-Generation Vaccine Development Beyond Current WHO-Approved Shots

About this episode

The episode discusses the rise in malaria cases and the development of next-generation vaccines in response to the limitations of current WHO-approved shots.

A Johns Hopkins University expert warns that malaria cases are rising globally despite the rollout of two WHO-approved vaccines, RTS,S (Mosquirix) and R21, now deployed in 24 countries since their approvals in 2021 and 2023, according to a Dailyhunt report from Madhyamam English. The vaccines reduce severe cases in children by over 50 percent in the first year after three doses, with a fourth recommended to extend waning protection, yet transmission persists amid challenges like supply and access. Rotary International highlights optimism from these breakthroughs, noting modeling by the WHO that scaled distribution could save half a million children's lives by 2035 in moderate- and high-transmission areas. Dozens of next-generation candidates are advancing, including Australia's Griffith University PlasProtecT vaccine, funded by over AU$3.1 million from Rotary District 9640. Unlike liver-stage focused shots, PlasProtecT targets the blood-stage parasite using killed whole-parasite proteins in a freeze-stable formulation effective against multiple strains. Phase 1 human trials are slated to begin this year, with Phase 2 data expected by 2028, potentially enabling rollout in endemic…

Topics covered

• malaria
• vaccine development
• public health
• global health
• immunology
• child health

Keywords

• malaria
• vaccine
• RTS,S
• R21
• Griffith University
• immunology
• public health
• child mortality
• vaccine trials

Mentioned in this episode

Organizations: Johns Hopkins University, Rotary International, Griffith University

Products: RTS,S (Mosquirix), R21

Places: Uganda

More episodes of Malaria Vaccine

• **Next-Generation Malaria Vaccine R78C Offers Hope as Global Cases Rise to 282 Million** · May 5, 2026 · 4 min
• Oxford and Serum Institute Launch R78C Next-Generation Malaria Vaccine to Transform Treatment Across Africa · May 3, 2026 · 2 min
• Malaria Vaccine Updates: Where to Find the Latest News and Official Health Resources · May 1, 2026 · 1 min
• Malaria Vaccines Transform Africa: 32% Case Drop in Burkina Faso Despite Funding and Misinformation Challenges · April 28, 2026 · 2 min
• R21 Malaria Vaccine Dramatically Cuts Cases and Deaths Across Africa, But Funding Gaps and Misinformation Threaten Progress · April 26, 2026 · 2 min
• Malaria Vaccine Rollout Stalled by Funding Cuts and Misinformation Despite Scientific Breakthroughs · April 24, 2026 · 4 min